Business · 11/07/2016Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Compounded Drug Products
Summary
The FDA is releasing a draft guidance to clarify its policies on compounded drug products that are essentially copies of approved drugs, in order to help industry comply with the exemptions under the FD&C Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →